*
Microsoft ( MSFT ) forms MAI Superintelligence Team starting with
AI for
medical diagnostics
*
Company to invest heavily on effort targeting specialist
AI
models
*
Microsoft AI chief predicts 'medical superintelligence'
for
diagnosis in 2-3 years
By Jeffrey Dastin
SAN FRANCISCO, Nov 6 (Reuters) - Microsoft ( MSFT ) is forming a
new team that wants to build artificial intelligence that is
vastly more capable than humans in certain domains, starting
with medical diagnostics, the executive leading the effort told
Reuters.
Called the MAI Superintelligence Team, the project follows
similar efforts by Meta Platforms, Safe Superintelligence Inc
and others that have begun targeting technical leaps while
garnering skepticism for their ability to deliver, absent new
breakthroughs.
Microsoft ( MSFT ) plans to invest "a lot of money" on the
project as well, said Mustafa Suleyman, the AI chief in charge.
Meta this year offered $100 million signing bonuses to recruit
famous AI talent. Suleyman declined to say if such offers or
poaching attempts were on the table. However, he said Microsoft
AI would continue to recruit from other top labs while staffing
its new team with existing researchers and Karen Simonyan as
chief scientist.
Microsoft's ( MSFT ) effort comes with a twist. According to
Suleyman, the company is not chasing "infinitely capable
generalist" AI like some peers. The reason, he said, is he
doubts that autonomous, self-improving machines could be
controlled, despite research into how humanity might keep AI in
check.
He said Microsoft ( MSFT ) has a vision for "humanist
superintelligence," or technology that could solve defined
problems with a real-world benefit.
"Humanism requires us to always ask the question: does this
technology serve human interests?" said Suleyman.
AI theorists and developers have long debated whether the
technology may lead to imminent danger or poses no harm relative
to problems such as machine-learned bias and trustworthiness.
Suleyman said he aims to focus the Microsoft ( MSFT ) team on
specialist models that achieve what he called superhuman
performance while posing "virtually no existential risk
whatsoever." He gave as examples AI that solves battery storage
or develops molecules, in a nod to AlphaFold, DeepMind's AI
models that can predict protein structures. Suleyman was a
DeepMind co-founder.
Suleyman said that for diagnosis, a domain long of interest to
the AI field and one that Microsoft ( MSFT ) has focused on, the company
has a "line of sight to medical superintelligence in the next
two to three years."
He said the effort is based on AI that reasons through
problems and still would require breakthroughs. But if achieved,
he said the AI would "increase our life expectancy and give
everybody more healthy years, because we'll be able to detect
preventable diseases much earlier."